Sensible Diagnostics Gets $1M NIH RADx Award for COVID Test Development
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 21, 2023 | Covid 19 |
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 15, 2023 | Cancer |
The population genomics program will identify participants’ risk for cancer and other life-threatening diseases with a single test.
Read MorePosted by Chris Wolski | Aug 7, 2023 | Diabetes & Metabolic Diseases |
While A1c is the diagnostic gold standard for determining if a patient has diabetes, there are a variety of tests that provide flexibility.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Coagulation Testing |
HemoSonics announced its Quantra Hemostasis System received an Innovative Technology contract award from Vizient.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Respiratory Disease |
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read More